Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
SCB01A
DRUG
4 trials
Sponsors
SynCore Biotechnology Co., Ltd.
Conditions
Head and Neck Neoplasms
Head and Neck Squamous Cell Carcinoma
Malignant Solid Tumour
Solid Tumors
Phase 1
A Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard Therapy
Completed
NCT01159522
SynCore Biotechnology Co., Ltd.
Solid Tumors
Start: 2011-04-30
End: 2017-07-11
Updated: 2017-10-19
Phase 2
Study of SCB01A in Patient With Head and Neck Cancer
Terminated
NCT02488629
SynCore Biotechnology Co., Ltd.
Head and Neck Squamous Cell Carcinoma
Start: 2015-09-30
End: 2017-12-31
Updated: 2023-06-27
To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer
Terminated
NCT03020823
SynCore Biotechnology Co., Ltd.
Head and Neck Neoplasms
Start: 2017-04-30
End: 2018-11-20
Updated: 2023-06-05
Unknown Phase
Long-Term Compassionate Use Study for Continued Administration of SCB01A-01
NCT01151930
SynCore Biotechnology Co., Ltd.
Malignant Solid Tumour
Updated: 2020-11-17